Navigation Links
BioRestorative Therapies, Inc. Begins Trading Under New Name and Symbol ("BRTX")

JUPITER, Fla., Sept. 19, 2011 /PRNewswire/ -- BioRestorative Therapies, Inc. (OTCQB: BRTX) (the "Company"), formerly known as Stem Cell Assurance, Inc., today announced that its common stock is now trading on the OTCQB market under its new name, BioRestorative Therapies, Inc., and that the trading symbol for its common stock has been changed from "SCLZ" to "BRTX."

Mark Weinreb, the Company's Chairman and Chief Executive Officer, said, "The commencement of trading using our new symbol and name is one more positive step in positioning BRT as an emerging player in the stem cell arena. This helps signal the beginning of our branding of the Company and the initiatives we are pursuing."

About BioRestorative Therapies, Inc.

BioRestorative Therapies, Inc.'s goal is to become a medical center of excellence using cell and tissue protocols, primarily involving a patient's own (autologous) adult stem cells (non-embryonic), allowing patients to undergo cellular-based treatments. In June 2011, the Company launched a platform technology that involves the use of a brown fat cell-based therapeutic/aesthetic program, known as the ThermoStem Program.  The ThermoStem program will focus on treatments for obesity, weight loss, diabetes, hypertension, other metabolic disorders and cardiac deficiencies and will involve the study of stem cells, several genes, proteins and/or mechanisms that are related to these diseases and disorders.  As more and more cellular therapies become standard of care, the Company believes its strength will be its focus on the unity of medical and scientific explanations for clinical procedures and outcomes for future personal medical applications.  The Company also plans to offer and sell facial creams and products under the Stem Pearls™ brand.

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including those set forth in the Company's Form 10, as amended, filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.

Mark Weinreb
Tel: (561) 904-6070
Fax: (561) 429-5684

SOURCE BioRestorative Therapies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioRestorative Therapies, Inc. Announces Upgrade to OTCQB Market
2. Stem Cell Assurance, Inc. Announces Change of Name to BioRestorative Therapies, Inc.
3. Course correction needed for Alzheimers therapies, experts warn
4. As New Data Wave Begins, a Gene Study in One Disease Discovers Mutations in an Unrelated Disease
5. Austen BioInnovation Institute in Akron Begins Work on Roadmap for First U.S. Accountable Care Community
6. Vaxart Begins First Oral Vaccine Clinical Trial
7. BioNeutral to Premier its EPA-Approved Ygiene® 206 Hospital-Grade Disinfectant at the Annual 2011 APIC Conference, While Community Health of South Florida Begins Product Review
8. Tissue Genesis Begins FDA-Approved Clinical Trial
9. Wind tunnel begins operations at Empa in Duebendorf
10. Biotech Begins Year on a Quiet, but Optimistic Note
11. USDA scientists discover how foot-and-mouth disease virus begins infection in cattle
Post Your Comments:
(Date:11/26/2015)... MUMBAI , November 26, 2015 ... --> Accutest Research ... accredited Contract Research Organization (CRO), has ... Chase Cancer Center - Temple Health ... ,     (Photo: ) ...
(Date:11/25/2015)... 26, 2015 --> ... 2016 - 2020 report analyzes that automating biobanking ... quality in long-term samples, minimizing manual errors, improving ... minimizes manual errors such as mislabeling or inaccurate ... it plays a vital role in blood fractionation, ...
(Date:11/25/2015)... , November 25, 2015 2 ... première fois les différences entre les souches bactériennes ... celles des êtres humains . Ces recherches ... et envisager la prise en charge efficace de ... diagnostiqués chez les chats .    --> ...
(Date:11/25/2015)... and HOLLISTON, Mass. , Nov. 25, ... HART ), a biotechnology company developing bioengineered organ ... Jim McGorry will present at the LD Micro ... at 2:30 p.m. PT. The presentation will be webcast ... days. Management will also be available at the conference ...
Breaking Biology Technology:
(Date:10/29/2015)... Today, LifeBEAM , a leader ... a global leader in technical performance sports clothing ... advanced bio-sensing technology. The hat will allow fitness ... biometrics to improve overall training performance. As a ... bring together the most advanced technology, extensive understanding ...
(Date:10/27/2015)... 2015 Munich, Germany ... technology (ASGM) automatically maps data from mobile eye tracking ... , so that they can be quantitatively analyzed with ... Munich, Germany , October 28-29, 2015. SMI,s Automated ... mobile eye tracking videos created with SMI,s Eye ...
(Date:10/26/2015)... India , October 26, 2015 ... --> adds ... 2015 to 2021 as well as ... 2015-2019 research reports to its collection ... . --> ...
Breaking Biology News(10 mins):